Induction of interleukin 1 secretion and enhancement of humoral immunity by binding of human C5a to macrophage surface C5a receptors.

PubWeight™: 1.35‹?› | Rank: Top 10%

🔗 View Article (PMC 2186785)

Published in J Exp Med on September 01, 1982

Authors

M G Goodman, D E Chenoweth, W O Weigle

Articles citing this

Secretory products of macrophages. J Clin Invest (1987) 10.33

Local opsonization by secreted macrophage complement components. Role of receptors for complement in uptake of zymosan. J Exp Med (1984) 2.53

Release of interleukin-1 beta associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes. Infect Immun (1989) 2.42

C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha. J Exp Med (1988) 1.67

C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Intensive Care Med (1993) 1.45

Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. Am J Pathol (2002) 1.33

Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am J Pathol (1994) 1.28

Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC). Clin Exp Immunol (1993) 1.15

Provocation of pulmonary vascular endothelial injury in rabbits by human recombinant interleukin-1 beta. Infect Immun (1988) 1.15

Glomerular cells and macrophages in the progression of experimental focal and segmental glomerulosclerosis. Am J Pathol (1989) 1.01

Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds. Infect Immun (1986) 1.01

Time course of gene expression of inflammatory mediators in rat lung after diesel exhaust particle exposure. Environ Health Perspect (2005) 0.97

The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukin-1. Immunology (1991) 0.97

The sources of inflammatory mediators in the lung after silica exposure. Environ Health Perspect (2004) 0.96

Concentrations of glycosaminoglycans in synovial fluids and their relation with immunological and inflammatory mediators in rheumatoid arthritis. Ann Rheum Dis (1990) 0.93

Mesangial cell immune injury. Synthesis, origin, and role of eicosanoids. J Clin Invest (1991) 0.88

Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis. Am J Pathol (1993) 0.88

Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin. Immunology (2001) 0.87

The role of complement in the induction and regulation of immune responses. Immunology (1984) 0.84

Inflammatory intermediaries in inflammatory bowel disease. Int J Colorectal Dis (1989) 0.82

Antibody-mediated enhancement of Legionella pneumophila-induced interleukin 1 activity. Infect Immun (1993) 0.81

Biological properties of human C5a: selected in vitro and in vivo studies. Clin Exp Immunol (1988) 0.80

The search for an endogenous activator. Yale J Biol Med (1985) 0.79

Effects of two types of cobra venom factor on porcine complement activation and pulmonary artery pressure. Clin Exp Immunol (1989) 0.77

Perspectives for the future. Intensive Care Med (1993) 0.77

Cardiomyopathy is linked to complement activation. Am J Pathol (2002) 0.77

Articles cited by this

Immunization of dissociated spleen cell cultures from normal mice. J Exp Med (1967) 30.93

T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol (1978) 28.92

Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes. J Immunol (1978) 5.36

Bidirectional amplification of macrophage-lymphocyte interactions: enhanced lymphocyte activation factor production by activated adherent mouse peritoneal cells. J Immunol (1977) 2.73

The lymphocyte surface. II. Separation of Fc receptor, C'3 receptor and surface immunoglobulin-bearing lymphocytes. Proc R Soc Lond B Biol Sci (1974) 1.76

The generation of memory cells. I. The role of C3 in the generation of B memory cells. Immunology (1977) 1.59

Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages. J Exp Med (1982) 1.28

Stimulation of murine B lymphocytes by isolated C3b. J Exp Med (1975) 1.25

Evaluation of the role of C4 in the cellular immune response in vitro. J Immunol (1979) 1.11

Antigen-nonspecific helper factors in the antibody response. Fed Proc (1982) 1.07

Role of C3 in the regulation of a splenic PFC response in rabbits. J Immunol (1980) 1.05

Potentiation of the primary humoral immune response in vitro by C5a anaphylatoxin. J Immunol (1982) 1.01

Stimulation of the release of a B cell-activating factor from human monocytes. Cell Immunol (1976) 1.00

Lymphocyte traffic through antigen-stimulated lymph nodes. I. Complement activation within lymph nodes initiates cell shutdown. Immunology (1981) 0.98

Inhibition of lymphocyte blastogenesis by C3c and C3d. J Immunol (1979) 0.97

Articles by these authors

Kinetic differences in unresponsiveness of thymus and bone marrow cells. Science (1971) 4.13

A modification of the hemolytic plaque assay for use with protein antigens. J Immunol (1968) 4.02

Immunoglobulins cytophilic for human lymphocytes, monocytes, and neutrophils. J Clin Invest (1975) 3.39

Immunologic properties of bacterial lipopolysaccharide (LPS): correlation between the mitogenic, adjuvant, and immunogenic activities. J Immunol (1975) 3.18

Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A (1978) 3.08

Cellular sites of immunologic unresponsiveness. Proc Natl Acad Sci U S A (1970) 3.01

Immunological unresponsiveness. Adv Immunol (1973) 2.75

Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med (1981) 2.63

Relationship of the structure of bacterial lipopolysaccharides to its function in mitogenesis and adjuvanticity. Proc Natl Acad Sci U S A (1973) 2.61

Patterns of cytokine gene expression by CD4+ T cells from young and old mice. J Immunol (1993) 2.56

Recent observations and concepts in immunological unresponsiveness and autoimmunity. Clin Exp Immunol (1971) 2.45

Mechanism of action of the group A streptococcal C5a inactivator. Proc Natl Acad Sci U S A (1985) 2.38

Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg (1983) 2.29

Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis. Adv Immunol (1980) 2.27

Immunologic properties of bacterial lipopolysaccharide (LPS). II. The unresponsiveness of C3H/HeJ Mouse spleen cells to LPS-induced mitogenesis is dependent on the method used to extract LPS. J Exp Med (1975) 2.22

Termination of tolerance to human gamma globulin in mice by antigen and bacterial lipopolysaccharide (endotoxin). J Exp Med (1973) 2.15

Transfer of experimental autoimmune thyroiditis by serum from thyroidectomized donors. J Exp Med (1969) 2.12

The production of thyroiditis and antibody following injection of unaltered thyroglobulin without adjuvant into rabbits previously stimulated with altered thyroglobulin. J Exp Med (1965) 1.96

The age-associated increase in IFN-gamma synthesis by mouse CD8+ T cells correlates with shifts in the frequencies of cell subsets defined by membrane CD44, CD45RB, 3G11, and MEL-14 expression. J Immunol (1993) 1.88

Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice. J Virol (1998) 1.86

The production of antisera to human gammaGlobulin subclasses in rabbits using immunological unresponsiveness. J Immunol (1968) 1.82

Studies on the induction of immunologic unresponsiveness. 3. Antigen form and mouse strain variation. J Immunol (1969) 1.81

Differences in the expression profiles of CD45RB, Pgp-1, and 3G11 membrane antigens and in the patterns of lymphokine secretion by splenic CD4+ T cells from young and aged mice. J Immunol (1990) 1.79

Cellular events during induction of immunologic unresponsiveness in adult mice. J Immunol (1971) 1.72

Studies on the induction of immunologic unresponsiveness. II. Kinetics. J Immunol (1967) 1.70

Cellular events in the induction of experimental allergic encephalomyelitis in rats. J Exp Med (1976) 1.69

The cellular and subcellular bases of immunosenescence. Adv Immunol (1989) 1.59

A modified method for chemotaxis under agarose. J Immunol Methods (1979) 1.55

B-lymphocytes activation by the Fc region of IgG. J Exp Med (1977) 1.51

Cyclical production of antibody as a regulatory mechanism in the immune response. Adv Immunol (1975) 1.50

The ability of bacterial lipopolysaccharide to modulate the induction of unresponsiveness to a state of immunity. Cellular parameters. J Exp Med (1973) 1.49

Interstitial immune complex thyroiditis in mice: the role of autoantibody to thyroglobulin. J Exp Med (1974) 1.49

Lymphokines and aging: interleukin-2 production and activity in aged animals. J Immunol (1981) 1.48

Studies on the induction of immunologic unresponsiveness. I. Effects of endotoxin and phytochemagglutinin. J Immunol (1967) 1.47

Biocompatibility of hemodialysis membranes: evaluation in an ovine model. J Lab Clin Med (1993) 1.46

Effect of immunological unresponsiveness on different cell populations. Transplant Rev (1972) 1.45

Human C5a and C5a analogs as probes of the neutrophil C5a receptor. Mol Immunol (1980) 1.41

Regulation of immune response by components of the complement cascade and their activated fragments. Springer Semin Immunopathol (1983) 1.41

Roles of T and B lymphocytes in the termination of unresponsiveness to autologous thyroglobulin in mice. J Exp Med (1974) 1.38

Nonspecific activation of murine lymphocytes. I. Proliferation and polyclonal activation induced by 2-mercaptoethanol and alpha-thioglycerol. J Exp Med (1977) 1.37

Effect of chronic viral infection on the immune system. I. Comparison of the immune responsiveness of mice chronically infected with LCM virus with that of noninfected mice. J Immunol (1973) 1.36

The development of autoimmune thyroiditis in rabbits following injection of aqueous preparations of heterologous thyroglobulins. J Immunol (1967) 1.35

HIV-1 and its envelope glycoprotein down-regulate chemotactic ligand receptors and chemotactic function of peripheral blood monocytes. J Immunol (1989) 1.34

Immunologic properties of bacterial lipopolysaccharide (LPS). III. Genetic linkage between the in vitro mitogenic and in vivo adjuvant properties of LPS. J Exp Med (1976) 1.34

Cell-mediated immunity in aged mice: an underlying lesion in IL 2 synthesis. J Immunol (1982) 1.33

CD4+ T cell activation and tolerance induction in B cell knockout mice. J Exp Med (1996) 1.32

Th1 and Th2 clones differ in their response to a tolerogenic signal. J Immunol (1990) 1.31

Specific suppression of the immune response by HGG tolerant spleen cells. I. Parameters affecting the level of suppression. J Immunol (1976) 1.30

Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg. J Immunol (1985) 1.30

Induction and mode of action of suppressor cells generated against human gamma globulin. I. An immunologic unresponsive state devoid of demonstrable suppressor cells. J Exp Med (1978) 1.29

Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages. J Exp Med (1982) 1.28

Transfer of experimental autoimmune thyroiditis with T cell clones. J Immunol (1987) 1.28

Tolerogenicity of resting and activated B cells. J Exp Med (1994) 1.25

The immune response to human gamma-G-immunoglobulin in rabbits unresponsive to Fc fragment and H chain protein. J Immunol (1967) 1.25

The termination of immunological unresponsiveness to bovine serum albumin in rabbits. I. Quantitative and qualitative response to cross-reacting albumins. J Exp Med (1970) 1.24

In vivo induction of tolerance in murine CD4+ cell subsets. J Exp Med (1993) 1.22

T cell regulation of polyclonal B cell responsiveness. I. Helper effects of T cells. J Immunol (1979) 1.21

Immunologic unresponsiveness after gastric administration of human gamma-globulin: antigen requirements and cellular parameters. J Immunol (1980) 1.20

Fate of antigen-binding cells in unresponsive and immune mice. J Exp Med (1973) 1.20

The effect of antigenic competition on antibody production to heterologous proteins, termination of immunologic unresponsiveness and induction of autoimmunity. J Immunol (1967) 1.17

Co-expression of chemotactic ligand receptors on human peripheral blood monocytes. J Immunol (1987) 1.16

The requirement for adherent cells in the Fc fragment-induced proliferative response of murine spleen cells. J Exp Med (1979) 1.15

Specific, transient suppression of the immune response by HGG tolerant spleen cells. II. Effector cells and target cells. J Immunol (1976) 1.14

The behavior of autologous thyroglobulin in the circulation of rabbits immunized with either heterologous or altered homologous thyroglobulin. J Immunol (1967) 1.13

Immunologic responsiveness of the C3H/HeJ mouse: differential ability of butanol-extracted lipopolysaccharide (LPS) to evoke LPS-mediated effects. J Exp Med (1978) 1.13

Regulation of Fc fragment-induced murine spleen cell proliferation. J Exp Med (1980) 1.12

Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes. J Immunol (1984) 1.11

Response of human neutrophils to C5a: a role for the oligosaccharide moiety of human C5ades Arg-74 but not of C5a in biologic activity. J Immunol (1981) 1.10

Studies on the catabolism of gamma- G subunits and chains. J Immunol (1965) 1.10

The induction of peripheral T cell unresponsiveness in adult mice by monomeric human gamma-globulin. J Immunol (1989) 1.09

Quantitative comparisons of neutrophil chemotaxis in four animal species. Clin Immunol Immunopathol (1980) 1.09

Splenic role in the regulation of immune responses. Cell Immunol (1977) 1.09

2,4-Dinitrophenyl receptors on mouse thymus and spleen cells. J Exp Med (1973) 1.07

Inability of the C3a anaphylatoxin to promote cellular lysis. Nature (1980) 1.07

Polyclonal activation of human B lymphocytes by Fc fragments. I. Characterization of the cellular requirements for Fc fragment-mediated polyclonal antibody secretion by human peripheral blood B lymphocytes. J Exp Med (1981) 1.07

Th1 cell anergy and blockade in G1a phase of the cell cycle. J Immunol (1993) 1.07

Possible roles of suppressor cells in immunologic tolerance. Transplant Rev (1975) 1.07

Anti-bovine serum albumin specificity and binding affinity after termination of tolerance to bovine serum albumin. J Immunol (1965) 1.06

C5a and thromboxane generation associated with pulmonary vaso- and broncho-constriction during protamine reversal of heparin. Anesthesiology (1987) 1.06

Role of C3 in the regulation of a splenic PFC response in rabbits. J Immunol (1980) 1.05

The C5a receptor of neutrophils and macrophages. Agents Actions Suppl (1983) 1.05

Polyclonal activation of murine B lymphocytes by Fc fragments. I. The requirement for two signals in the generation of the polyclonal antibody response induced by Fc fragments. J Immunol (1980) 1.04

Passive transfer of experimental allergic encephalomyelitis by myelin basic protein-specific L3T4+ T cell clones possessing several functions. J Immunol (1986) 1.04

Polyclonal B lymphocyte activation during Trypanosoma cruzi infection. J Immunol (1980) 1.03

Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes. J Immunol (1990) 1.03

The in vivo formation and fate of antigen-antibody complexes formed by fragments and polypeptide chains of rabbit gamma-G-antibodies. J Exp Med (1966) 1.03

The antibody response in rabbits to previously tolerated antigens. Ann N Y Acad Sci (1965) 1.03

In vivo behavior of homologous and heterologous thyroglobulin and induction of immunologic unresponsiveness to heterologous thyroglobulin. J Immunol (1967) 1.03

Regulation of the immune response. I. The potentiation of in vivo and in vitro immune responses by Fc fragments. J Exp Med (1980) 1.02

Effect of lipopolysaccharide on immunogenicity and tolerogenicity of HGG in C57BL/6J nude mice: evidence for a possible B cell deficiency. J Immunol (1977) 1.02

Nonspecific activation of murine lymphocytes. IV. Proliferation of a distinct, late maturing lymphocyte subpopulation induced by 2-mercaptoethanol. J Immunol (1978) 1.02

Anaphylatoxin-mediated regulation of the immune response. II. C5a-mediated enhancement of human humoral and T cell-mediated immune responses. J Immunol (1983) 1.02